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BACKGROUND: The literature shows considerable between-study variation in the prevalence of post-traumatic stress symptoms (PTSS)
among women with breast cancer. Our aim was, therefore, to explore the prevalence of and risk factors for cancer-related PTSS in
a nationwide inception cohort of women treated for primary breast cancer.
METHODS: In all, 68% of all Danish women receiving surgery for primary breast cancer between October 2001 and March 2004
completed a questionnaire at 3 months post surgery (n¼3343), which included the impact of event scale (IES). In all, 94% of the
disease-free women also completed a follow-up questionnaire at 15 months post surgery. Data on pre-cancer demographic,
socioeconomic, and psychiatric status were obtained from national registries. The Danish Breast Cancer Cooperative Group and
surgical departments provided information on disease variables, treatment, and comorbidity.
RESULTS: At 3 months post surgery, 20.1% had IES total scores suggesting severe PTSS (X35), compared with 14.3% at 15 months.
In all, 48% with severe PTSS at 3 months also had scores above the cutoff at 15 months. Main predictors of severe PTSS at 15 months
were low social status, previous physical and mental illness, axillary lymph node involvement (43), and reduced physical functioning
(PF) at 3 months.
CONCLUSION: The results confirm that receiving a breast cancer diagnosis can be a significant traumatic experience, and that many
women experience persistent cancer-related PTSS. Low social status, poor health status, low levels of PF, and disease severity were
found to be risk factors for severe PTSS.
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A breast cancer diagnosis is a potential life-threatening event
associated with significant distress (Kunkel and Chen, 2003;
Somerset et al, 2004). Even after successful treatment, cancer
diagnosis and treatment may continue to be a source of distress
(Mehnert and Koch, 2007). Post-traumatic stress can occur after an
individual is exposed to an event perceived as life threatening, and
associated with intense fear, helplessness, or horror (American
Psychiatric Association, 2000). In 1994, the trauma criteria of
post-traumatic stress disorder (PTSD) in DSM-IV were expanded
to include life-threatening illness, such as cancer (American
Psychiatric Association, 2000). According to DSM-IV, the disorder
is defined by a set of symptoms (re-experiencing, avoidance, and
hyper-arousal) lasting at least 1 month.
There is considerable variation in the proportion of individuals
exposed to traumatic events who develop post-traumatic stress
symptoms (PTSS) of sufficient severity to warrant a diagnosis of
PTSD (Passik and Grummon, 1998; Smith et al, 1999; Gurevich
et al, 2002). This is also the case for studies focusing on the
prevalence of PTSS in breast cancer (Hegel et al, 2006; Mehnert
et al, 2009), with reported prevalence of suspected or diagnosed
PTSD ranging from 32% in a sample of 31 women with stage I–III
breast cancer on average at 16 months after treatment (Naidich
and Motta, 2000) to 0.0% in a sample of 74 breast cancer survivors
at 3 to 6 years after diagnosis (Matsuoka et al, 2002). As suggested
in reviews (Gurevich et al, 2002; Kangas et al, 2002; Matsuoka et al,
2002), this variability may stem from several between- and within-
study differences in research designs. First, the available studies
mostly involve relatively small samples of convenience, ranging
from 31 (Naidich and Motta, 2000) to 352 women (Han et al,
2002), with one cross-sectional study including 1083 women
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s(Mehnert et al, 2009) as the exception. Second, most studies have
used cross-sectional designs (e.g., Hegel et al, 2006; Mehnert et al,
2009). Third, the timing of assessment varies considerably, from a
few weeks to 23 years after treatment (Cordova et al, 1995; Baider
and Kaplan, 1997; Butler et al, 1999; Andrykowski et al, 2000;
Baider et al, 2000; Vickberg et al, 2000; Kornblith et al, 2003).
Fourth, the assessment instruments and diagnostic criteria vary,
although more than half of the studies have used the 15-item
impact of event scale (IES; Horowitz et al, 1979). Finally, although
younger age, lower income, less education, physical and psychia-
tric co-morbidity, and physical functioning (PF) have been
proposed as general risk factors of severe post-traumatic stress
(Kessler et al, 1995; Ullman and Siegel, 1996; Luecken et al, 2004;
Palmer et al, 2004; Palyo and Beck, 2005; Hegel et al, 2006; Schlich-
Bakker et al, 2009), only few studies have conducted multivariate
data analysis while adjusting for potential confounders (e.g., age;
Cordova et al, 1995; Green et al, 1998; Kornblith et al, 2003).
Although the available results suggest that women treated for
breast cancer may be at increased risk of cancer-related post-
traumatic stress, the considerable variability in the prevalence of
PTSSs the literature calls for large, population-based studies,
addressing the methodological limitations of the available studies.
We, therefore, assessed PTSS and the role of several potential risk
factors in a large nationwide cohort of Danish women treated for
primary breast cancer at 3 months after surgery, and again at
12 months later. Our study is, to the best of our knowledge, the
first nationwide questionnaire-based prospective study of post-
traumatic stress in cancer patients.
PATIENTS AND METHODS
Study design
The study was designed as a nationwide cohort study of 4917
Danish women with primary breast cancer who underwent surgery
between October 2001 and March 2004, and were treated in
accordance with the standardised guidelines provided by the
Danish Breast Cancer Cooperative Group (DBCG). Details con-
cerning the cohort have previously been published (Christensen
et al, 2009). The eligible women were informed about the study at
the surgical departments, and the Charlson comorbidity index
(CCI; Charlson et al, 1987) was completed for each patient.
Information on eligibility, comorbidity, histopathology, and
treatment were obtained directly from the surgical departments,
and/or from the DBCG and the CPR registry. All Danish residents
have a unique 10-digit personal identification number (CPR
number), which is used across all public registration systems,
making linkages between various registry-based databases possible.
Demographic data, psychiatric history and socioeconomic
variables were collected from six nationwide Danish registries
through a linkage serviced by Statistics Denmark (Statistics
Denmark, 2010). The study was approved by The Regional Science
Ethics Committees and The Danish Data Protection Agency.
Inclusion criteria
Eligible patients at 3 months post surgery were 18–70 years old
resident Danish women with histologically confirmed breast
cancer T1-3, N0-3, and M0 according to the tumour–node–
metastasis staging system (Singletary et al, 2002), and no history of
other cancers, except non-melanoma skin cancer or carcinoma
in situ of the cervix uteri. Because of the considerable variation in
the treatment procedures for patients not receiving standard
treatment, only women eligible for the DBCG treatment protocols
during the study period were included, thus excluding women
younger than 18 or older than 70 years. Additional requirements
were: ability to read Danish and being capable of completing
a questionnaire. Eligible patients at 15 months post surgery were
disease free as verified by the DBCG.
The questionnaire cohort
At approximately 3 months post surgery, 3343 (68.0%) women
provided an additional information regarding health behaviours,
health status and a number of psychosocial variables through a
mail-out questionnaire. Responders were slightly younger than
non-responders (median 55.7 years vs 58.0 years; range: 26–70
years), but age-adjusted analyses showed the sample to be
nationally representative with respect to disease- and treatment-
related variables (Christensen et al, 2009). At 15 months post
surgery, 166 women had either died or suffered a recurrence, and
were excluded. On the basis of subsequently reported information,
two women did not meet the baseline inclusion criteria and were
excluded together with 47 women with unknown disease status
at 15 months post surgery. A total of 3128 women were eligible
15 months post surgery. Of these, 2931 (93.7%) returned a valid
questionnaire.
Measures
Post-traumatic stress symptom was assessed with the IES
(Horowitz et al, 1979). Although not a measure of PTSD per se,
which is diagnosed through clinical interviews, the high correla-
tions found between the IES and PTSD identified through clinical
interviews have supported its usefulness as a measure of post-
traumatic symptom severity (Neal et al, 1994; Sundin and
Horowitz, 2002, 2003; Brewin, 2005), and the IES has been used
in the majority of previous studies of women with breast cancer. In
addition to a total IES score, the IES yields scores on the two
subscales measuring seven intrusive symptoms and eight avoid-
ance symptoms relative to a specific stressor, in this case breast
cancer. Possible scores range from 0 to 75 (IES total), 0 to 35
(intrusive symptoms), and 0 to 40 (avoidance symptoms). The
cutoff levels for the IES have not been determined in cancer
patients, but a cutoff of X35 has demonstrated high sensitivity
(0.89) and specificity (0.94) for PTSD when validated against the
criteria of DSM-IV, as determined by a clinical diagnostic
interview (Wohlfarth et al, 2003). It should be noted that the IES
was developed before the latest revision of PTSD in 1994, and thus
does not include the hyper arousal dimension added in the present
diagnostic criteria of PTSD in the DSM-IV (American Psychiatric
Association, 2000). We therefore chose to apply the scale
conservatively as a broad indicator of PTSS, and not a direct
measure of PTSD. Consequently, in the following, the IES total
scores will be labelled PTSS, whereas the cutoff of X35 on the total
IES score will be labelled as severe PTSS (yes: ‘1’, no: ‘0’). The
internal consistencies (Cronbach’s a) of the IES in this study were
satisfactory (total: 0.89; avoidance: 0.88; intrusion: 0.81).
Covariates included the demographic and socioeconomic
variables: age at time of surgery, marital status, number of
children, educational level, social status, personal income, net-
wealth, urbanicity, ethnicity, and psychiatric history, using
relevant national registries (Christensen et al, 2009). These
variables refer to pre-cancer conditions either in the year before
the surgery minus 1 month or, when appropriate, the date of
surgery minus 1 month. Additional covariates included the
weighted index score of the CCI (Charlson et al, 1987; Extermann,
2000a,b), the PF subscale of the MOS short form (SF-36; Ware
and Sherbourne, 1992), the body mass index (BMI), smoking
habits, and alcohol use.
Missing values
On subscales with p50% missing values and Cronbach’s a 40.7,
missing values were substituted with the mean of the remaining
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sfilled items on the subscale (Schafer and Graham, 2002). Subscale
scores with 450% missing values were coded as missing and no
total score was calculated. This procedure is identical to the
procedure described in the SF-36 manual (Bjørner et al, 1997)
and is regarded as preferable to procedures such as list-wise
deleting or scale mean substitution of scale scores (Schafer and
Graham, 2002).
Statistical analysis
As the IES data were highly skewed, unadjusted comparisons
between independent variables and continuous IES scores (PTSS)
were conducted using non-parametric tests (Mann–Whitney
or Kruskal–Wallis) and the unadjusted comparisons between
independent variables and severe PTSS with w
2 tests. The adjusted
analyses were conducted with logistic regression analyses, with
severe PTSS (yes: ‘1’, no: ‘0’) as the dependant variable. Results are
presented as adjusted odds ratios (ORs).
The data were analysed according to the three phases of
the woman’s cancer history. Demographic factors and health
status were analysed at the first step, as these data refer to pre-
cancer conditions and, therefore, are unbiased by the cancer
experience. Information about the disease and treatment had
been known to the women for more than 2 months when the
questionnaire was completed, and the role of clinical variables
was therefore analysed at the second step. Post-treatment
psychosocial and health-related variables measured at 3 month
post surgery could potentially be moderated by the women’s
knowledge of the severity of their specific cancer diagnosis and
treatment, and were therefore analysed at the third step.
Associations between baseline covariates, PTSS, and severe
PTSS were analysed both at 3 months and 15 months post surgery.
At the first step, univariate associations between potential
predictors and PTSS and severe PTSS were assessed. Then, as
both PTSS and many predictors varied with age, associations
were adjusted for age. Finally, we explored predictors for severe
PTSS at 15 months post surgery, adjusting for 3-month scores
of PTSS and severe PTSS. At steps 2 and 3, the univariate
comparisons, both adjusted and unadjusted, were conducted as in
step 1. In addition, we also conservatively adjusted for variables
associated with severe PTSS (Po0.25) at the previous steps. Age
was treated as a continuous variable in all multivariate analyses.
Analyses were conducted with SPSS 16.0.2 for Windows Server
2003 R2 (SPSS Inc., Chicago, IL, USA).
RESULTS
Prevalence
The IES scores (PTSS) were imputed for 117 women at 3 months
post surgery and 129 women at 15 months. Of these, only 9 women
at 3 months and 4 women at 15 months had more than two missing
items on the IES.
Total IES scores (PTSS) could be calculated for all but 25 women
(n¼3318) at 3 months, and all but 19 women at 15 months
post surgery (n¼2912). As shown in Table 1, the prevalence of
severe PTSS was reduced from 20.1% at 3 months to 14.3% at
15 months (Po0.001). During the first year after surgery,
24.3% of the women had scores suggesting severe PTSS at one
or both measurements. Of the women with severe PTSS at
3 months, 48.4% also had scores above the cutoff at 15 months.
When analysing dropouts and women excluded at 15 months
post surgery (n¼424), the prevalence of severe PTSS at 3 months
was higher in dropouts (23.1%) than in non-dropouts
(19.6%). This difference was nonsignificant for severe PTSS
(w
2¼2.80; P¼0.09), but significant for PTSS scores (Z¼ 2.32;
P¼0.02).
Predictors
Step 1: sociodemographic and comorbidity-related predictors As
seen in Table 2, the likelihood of severe PTSS increased with
older age at 3 months, but not at 15 months, where the preva-
lence of older women (60–69 years) with severe PTSS had
decreased sharply from 23.2 to 13.4%, whereas the percentage
of young women (under 35 years) with severe PTSS doubled
from 5.3 to 12.3%. Women with children had higher risk of severe
PTSS at 3 months, but not at 15 months post surgery.
The socioeconomic status (SES) variables of education, occu-
pational status, personal income, and household net wealth per
person were all significant predictors of severe PTSS at 3 and
15 months post surgery in the age-adjusted analyses. Higher
educational level was a substantial predictor of lower risk of severe
PTSS at 3 and 15 months post surgery in both age-adjusted and
fully adjusted analyses. For example, the age-adjusted odds of
having severe PTSS at 3 months for women with a master’s degree
was only a third (OR¼0.36) compared with women with o8 years
of schooling. Lower income was consistently associated with
higher risk at 3 and 15 months, whereas the effect of lower net
wealth was most pronounced at 15 months. The SES variables of
education, personal income, and household net wealth also showed
to be significant predictors of severe PTSS at 15 months
independent of 3 months PTSS and severe PTSS. Having a pre-
cancer psychiatric history was consistently associated with
substantially higher risk of cancer-related severe PTSS at both
3 and 15 months post surgery. The same pattern emerged for
physical comorbidity. Psychiatric history, but not physical
comorbidity, was also a significant predictor at 15 months in the
3 months-adjusted analyses.
Step 2: clinical predictors As seen in Table 3, lymph node
involvement was consistently associated with markedly increased
PTSS scores and risk of having severe PTSS, both at 3 and 15
months. A trend was also observed in the 3 months-adjusted
analyses for nodal involvement to be predictive of sustained levels
of severe PTSS at 15 months compared with no involvement
(P¼0.08, data not shown). After adjusting for age, mastectomy
was significantly associated with higher risk of severe PTSS
compared with lumpectomy at 15 months, but not at 3 months.
After additional adjustment for nodal status however, type of
surgery was no longer significant (P¼0.89). The significant
Table 1 Cancer-related PTSS and severe PTSS among women treated
for primary breast cancer at 3 and 15 months post surgery
IES (cancer
related)
3 Months
post surgery
15 Months
post surgery
N 3318 2912
Intrusive thoughts Mean (s.d.): 10.1 (8.9) Mean (s.d.): 7.8 (7.9)
Median: 8 Median: 5
Range: 0–35 Range: 0–35
10–90 percentile 0–23 10–90 percentile 0–20
Avoidance Mean (s.d.): 10.0 (8.8) Mean (s.d.): 8.4 (8.7)
Median: 8 Median: 6
Range: 0–40 Range: 0–40
10–90 percentile 0–23 10–90 percentile 0–21
IES total (PTSS) Mean (s.d.): 20.1 (15.9) Mean (s.d.): 16.2 (15.3)
Median: 17 Median: 12
Range: 0–75 Range: 0–71
10–90 percentile 1–43 10–90 percentile 0–39
Severe PTSS: IES scores
X35 indicating severe
symptomatology
666 (20.1 %) 415 (14.3%)
Abbreviations: IES¼impact of event scale; PTSS¼post-traumatic stress symptom.
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sTable 2 Pre-diagnostic socio-demographic and health status risk factors for cancer-related PTSS and severe PTSS
a
3 Months post surgery 15 Months post surgery
PTSS
Severe
PTSS
Severe PTSS
age adjusted
PTSS
Severe
PTSS
Severe PTSS
age adjusted
Severe PTSS
3 months adjusted
b
N Mean (s.d.) (%) OR (95% CI) N Mean (s.d.) (%) OR (95% CI) OR (95 % CI)
Age P¼0.71 Po0.001 Po0.001
c Po0.001 P¼0.20 P¼0.20
c P¼0.07
26–35 years 95 17.05 (11.03) 6.3 1.00 (Referent) 73 17.36 (12.77) 12.3 1.00 (Referent) 1.00 (Referent)
36–49 years 900 19.76 (14.77) 17.2 3.09 1.33–7.18 773 17.39 (14.31) 12.9 1.06 0.51–2.19 0.57 0.26–1.26
50–59 years 1282 20.38 (16.17) 20.5 3.83 1.66–8.85 1126 16.68 (15.95) 16.0 1.35 0.66–2.77 0.69 0.32–1.49
60–69 years 1041 20.35 (16.69) 23.2 4.49 1.94–10.40 940 14.58 (15.47) 13.4 1.10 0.53–2.27 0.48 0.22–1.06
Marital status P¼0.47 P¼0.15 P¼0.44 P¼0.04 P¼0.33 P¼0.32 P¼0.17
Married or cohabiting 2537 19.90 (15.77) 19.4 1.00 (Referent) 2236 16.29 (15.35) 14.3 1.00 (Referent) 1.00 (Referent)
Divorced, separated or married – single 408 21.14 (15.97) 22.5 1.21 0.94–1.55 354 17.29 (15.70) 16.7 1.20 0.89–1.63 1.12 0.78–1.62
Widow – single 179 20.87 (16.78) 25.1 1.16 0.81–1.67 158 13.66 (14.90) 11.4 0.75 0.45–1.26 0.54 0.30–0.99
Unmarried – single 188 20.05 (15.79) 19.7 1.11 0.76–1.62 159 15.28 (14.67) 11.9 0.83 0.50–1.36 0.81 0.46–1.45
Children P¼0.16 P¼0.007 P¼0.01 P¼0.25 P¼0.08 P¼0.08 P¼0.53
No 384 18.70 (14.53) 14.8 1.00 (Referent) 326 15.02 (14.48) 11.0 1.00 (Referent) 1.00 (Referent)
Yes 2934 20.29 (16.01) 20.8 1.45 1.08–1.95 2586 16.36 (15.44) 14.7 1.38 0.96–1.98 1.15 0.75–1.75
Education (ISCED 97 based) P¼0.01 Po0.001 Po0.001 P¼0.26 Po0.001 Po0.001 P¼0.03
Lower secondary general (7 years) 539 22.42 (18.18) 27.8 1.00 (Referent) 466 16.55 (17.23) 18.0 1.00 (Referent) 1.00 (Referent)
Lower secondary general (8–10 years) 466 20.71 (16.65) 22.1 0.84 0.62–1.14 404 17.64 (16.29) 15.8 0.83 0.57–1.20 0.97 0.63–1.50
Upper secondary (11–13 years) 1317 20.41 (15.79) 20.3 0.74 0.58–0.95 1142 16.54 (15.47) 16.1 0.85 0.63–1.14 1.19 0.84–1.69
Tertiary o master degree (14–17 years) 797 18.29 (14.12) 15.2 0.53 0.40–0.71 718 14.97 (13.43) 9.2 0.44 0.31–0.64 0.68 0.45–1.03
Tertiary master degree (X18 years) 160 17.42 (12.24) 10.6 0.36 0.21–0.62 147 15.11 (13.43) 8.2 0.39 0.20–0.74 0.77 0.38–1.56
Social status (ISCO-88 based) Po0.001 Po0.001 Po0.001 P¼0.01 Po0.001 Po0.001 P¼0.38
Top manager or employee – upper level 381 16.72 (12.55) 11.5 1.00 (Referent) 338 14.92 (12.78) 8.6 1.00 (Referent) 1.00 (Referent)
Employee – medium level 559 18.92 (14.60) 16.1 1.48 1.01–2.19 502 15.61 (13.88) 11.2 1.32 0.83–2.12 1.02 0.60–1.74
Employee – basic level 820 19.64 (15.32) 17.3 1.61 1.12–2.31 704 16.17 (15.09) 13.6 1.67 1.08–2.59 1.21 0.74–1.97
Employee – others or in education 333 20.63 (16.84) 22.2 2.16 1.44–3.25 288 17.78 (16.29) 18.8 2.49 1.54–4.03 1.56 0.89–2.72
Self-employed or assisting spouse 124 20.42 (15.88) 20.2 1.88 1.10–3.24 111 14.67 (14.30) 12.6 1.58 0.80–3.12 0.89 0.40–2.00
Unemployed, recipient of temporary
allowance, cash or pre-retirement
benefits, and so on
619 20.95 (16.50) 23.4 2.18 1.49–3.20 556 15.44 (15.84) 14.9 2.03 1.27–3.23 1.12 0.68–1.86
Old age pension 169 21.61 (17.83) 27.2 2.52 1.52–4.16 155 14.82 (15.44) 14.8 2.16 1.15–4.07 0.86 0.43–1.71
Recipients of early retirement pension,
rehabilitation, or sickness benefits
306 24.60 (18.31) 32.4 3.48 2.32–5.20 252 20.55 (18.79) 23.4 3.47 2.12–5.66 1.53 0.87–2.68
Personal income P¼0.003 Po0.001 Po0.001 P¼0.007 Po0.001 Po0.001 P¼0.04
p20000 $ 499 22.35 (17.53) 28.1 1.00 (Referent) 436 18.67 (17.67) 20.0 1.00 (Referent) 1.00 (Referent)
420000 $ and p30000 $ 618 21.22 (17.31) 23.9 0.83 0.63–1.08 544 15.06 (15.85) 14.7 0.68 0.49–0.96 0.68 0.45–1.04
430000 $ and p40000 $ 688 20.94 (16.14) 21.9 0.78 0.59–1.03 600 17.11 (15.59) 17.7 0.82 0.59–1.13 1.04 0.71–1.54
440000 $ and p55000 $ 879 18.68 (14.60) 15.4 0.51 0.39–0.68 775 15.29 (13.95) 10.3 0.43 0.31–0.61 0.64 0.43–0.95
455000 $ 627 18.33 (13.88) 14.5 0.48 0.35–0.65 551 15.65 (14.05) 11.1 0.47 0.33–0.68 0.76 0.50–1.16
Household net wealth (per person) P¼0.15 P¼0.39 P¼0.03 Po0.001 P¼0.001 Po0.001 P¼0.02
o0 $ 677 20.99 (16.41) 21.6 1.00 (Referent) 571 18.37 (15.97) 18.4 1.00 (Referent) 1.00 (Referent)
X0 $ and o20000 $ 598 20.38 (15.52) 20.9 0.87 0.66–1.15 533 17.20 (15.82) 14.3 0.71 0.51–0.98 0.73 0.50–1.08
X20000 $ and o55000 $ 626 19.79 (15.95) 18.8 0.76 0.58–1.00 557 15.09 (14.94) 14.5 0.72 0.52–0.99 0.81 0.55–1.19
X55000 $ and o120000 $ 736 20.54 (15.98) 21.1 0.82 0.63–1.07 645 16.19 (15.68) 14.6 0.71 0.52–0.97 0.77 0.53–1.11
X120000 $ 674 18.84 (15.32) 18.0 0.64 0.48–0.85 600 14.28 (13.85) 9.7 0.43 0.30–0.62 0.50 0.33–0.75
Urbanicity (municipality size) P¼0.86 P¼0.95 P¼0.92 P¼0.94 P¼0.45 P¼0.47 P¼0.59
o10000 564 20.67 (16.22) 20.9 1.00 (Referent) 491 16.84 (15.92) 14.3 1.00 (Referent) 1.00 (Referent)
10000–50000 1201 20.10 (15.92) 20.1 0.92 0.72–1.18 1065 16.23 (15.62) 15.2 1.08 0.79–1.46 1.19 0.82–1.72
50000–300000 719 20.06 (15.93) 20.4 0.95 0.72–1.25 621 16.29 (15.49) 14.5 1.02 0.73–1.43 1.09 0.73–1.64
Copenhagen – suburbs 521 20.15 (15.58) 19.2 0.87 0.65–1.18 459 16.05 (14.66) 13.9 0.97 0.67–1.40 1.23 0.79–1.91
Copenhagen – center 307 19.20 (15.25) 19.2 0.91 0.64–1.29 271 15.14 (13.97) 10.7 0.72 0.46–1.14 0.84 0.49–1.44
Ethnicity P¼0.41 P¼0.66 P¼0.61 P¼0.63 P¼0.93 P¼0.93 P¼0.84
Not immigrant or descendant 3211 20.10 (15.91) 20.0 1.00 (Referent) 2821 16.20 (15.34) 14.3 1.00 (Referent) 1.00 (Referent)
Immigrant or descendant 101 20.55 (14.01) 21.8 1.13 0.70–1.84 86 16.83 (15.49) 14.0 0.97 0.52–1.81 1.07 0.54–2.15
Psychiatric history Po0.001 Po0.001 Po0.001 P¼0.002 Po0.001 Po0.001 P¼0.008
No 3090 19.72 (15.67) 19.1 1.00 (Referent) 2728 15.92 (15.11) 13.5 1.00 (Referent) 1.00 (Referent)
Yes 228 25.38 (17.29) 32.9 2.10 1.57–2.81 184 20.45 (17.94) 26.1 2.28 1.61–3.22 1.78 1.16–2.72
CCI P¼0.002 Po0.001 P¼0.001 P¼0.03 P¼0.001 P¼0.002 P¼0.26
No comorbidity 2955 19.78 (15.63) 19.2 1.00 (Referent) 2604 16.06 (15.27) 13.9 1.00 (Referent) 1.00 (Referent)
CCI score ¼1 296 22.27 (16.71) 26.0 1.38 1.05–1.83 251 16.66 (15.22) 14.7 1.07 0.74–1.55 0.84 0.55–1.31
CCI score 41 58 27.07 (19.81) 37.9 2.26 1.32–3.90 49 22.86 (18.24) 32.7 3.01 1.63–5.55 1.80 0.80–4.06
Abbreviations: CCI¼Charlson comorbidity index; CI¼confidence interval; IES¼impact of events scale; ISCED¼International Standard Classification of Education; ISCO-88¼
International Standard Classification of Occupation; OR¼odds ratio; PTSS¼post-traumatic stress symptom.
aPTSS¼IES; severe PTSS¼IES total score X35.
bAdjusted for
PTSS scores and severe PTSS measured at 3 months post surgery.
cUnadjusted. Age- and baseline-adjusted ORs in bold differs significantly (95% CI) from the reference group
(OR¼1.00). Missing observations are not shown. As a consequence totals (N) differs slightly.
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sassociation between nodal status and PTSS was largely unaffected
when adjusting for whether the women had undergone sentinel
node procedure and the number of lymph nodes involved (data
not shown). Having received or waiting to receive radiotherapy
was associated with higher risk of severe PTSS at 3 months, but not
at 15 months. But with additional adjustment for nodal status, this
relationship was also nonsignificant (P¼0.35), whereas nodal
status retained its significance (P¼0.01, data not shown). None of
the clinical variables were significant in the 3 months-adjusted
analyses (data not shown).
Step 3: health behaviours, BMI, and PF Poor PF at 3 months was
the only independent predictor of higher PTSS scores and higher
risk of severe PTSS both at 3 and 15 months post surgery in the
fully adjusted analyses (Table 4). PF demonstrated an approxi-
mately linear relationship with severe PTSS. Nearly four times as
many women with poor PF had severe PTSS, compared with those
with the highest PF. The same pattern was observed in the
3 months-adjusted analysis of severe PTSS at 15 months (P¼0.02,
data not shown).
DISCUSSION
This study is to our knowledge the first nationwide prospective
study of the prevalence of and potential risk factors for severe
PTSS following breast cancer. The strengths of the study include:
a large sample with an acceptable response rate at 3 months and
a very high response rate at 15 months (94%), a prospective design
using pre-cancer demographic factors and physical and psychiatric
co-morbidity, and detailed data on disease-related, treatment-
related, demographic, SES, and several important health-related
variables. All data refers to specific time points or periods relative
to the date of surgery.
When reviewing 16 studies of breast cancer patients published
between 1995 and 2010, in which mean IES scores were reported,
the mean intrusion scores reported varied from 1.24 to 22.0 and
avoidance scores from 1.36 to 24.6. The highest scores were found
in studies assessing cancer-related post-traumatic stress immedi-
ately after diagnosis or during treatment, whereas the lowest scores
were found in samples of breast cancer survivors assessed up
to 15 years post diagnosis. In addition to small samples (N from
Table 3 Clinical risk factors for cancer-related PTSS and severe PTSS
a
3 Months post surgery 15 Months post surgery
PTSS
Severe
PTSS
Severe PTSS
age adjusted
Severe PTSS
fully adjusted
b
PTSS
Severe
PTSS
Severe PTSS
age adjusted
Severe PTSS
fully adjusted
c
N Mean (s.d.) (%) OR (95% CI) OR (95% CI) N Mean (s.d.) (%) OR (95% CI) OR (95 % CI)
Tumour size P¼0.85 P¼0.45 P¼0.45 P¼0.58 P¼0.35 P¼0.35 P¼0.36 P¼0.46
p20mm 2009 19.99 (15.74) 19.5 1.00 (Referent) 1.00 (Referent) 1790 15.89 (15.19) 13.5 1.00 (Referent) 1.00 (Referent)
420mm and p50mm 1187 20.37 (16.14) 21.3 1.12 0.94–1.34 1.10 0.92–1.32 1019 16.83 (15.66) 15.5 1.17 0.94–1.46 1.15 0.92–1.44
450mm 101 20.33 (14.87) 19.8 1.05 0.63–1.73 1.04 0.62–1.73 85 16.51 (14.55) 14.1 1.05 0.56–1.97 0.98 0.52–1.86
Nodal status Po0.001 Po0.001 Po0.001 Po0.001 Po0.001 Po0.001 Po0.001 Po0.001
0 1632 18.89 (15.40) 17.4 1.00 (Referent) 1.00 (Referent) 1467 15.28 (14.99) 12.3 1.00 (Referent) 1.00 (Referent)
1–3 1080 20.63 (15.83) 21.3 1.30 1.07–1.58 1.30 1.06–1.59 968 16.22 (15.20) 14.0 1.16 0.92–1.48 1.17 0.91–1.49
43 594 22.58 (16.77) 25.4 1.68 1.34–2.11 1.61 1.28–2.03 468 19.24 (16.32) 20.5 1.84 1.40–2.42 1.81 1.37–2.40
Tumour grade P¼0.82 P¼0.88 P¼0.98 P¼0.99 P¼0.02 P¼0.26 P¼0.26 P¼0.46
I 789 19.92 (16.21) 20.0 1.00 (Referent) 1.00 (Referent) 725 15.41 (15.33) 13.2 1.00 (Referent) 1.00 (Referent)
II 1189 20.35 (15.90) 20.4 1.04 0.83–1.30 1.01 0.80–1.27 1043 16.85 (15.86) 16.0 1.25 0.95–1.64 1.20 0.91–1.59
III 686 20.23 (15.60) 19.1 1.01 0.78–1.31 0.99 0.75–1.29 564 17.09 (14.82) 13.7 1.04 0.75–1.44 1.04 0.75–1.45
Non-ductal carcinoma 624 19.95 (15.66) 20.8 1.05 0.81–1.36 1.03 0.79–1.34 557 15.26 (14.87) 13.1 0.99 0.71–1.37 0.98 0.70–1.37
ER/PR receptor status P¼0.82 P¼0.88 P¼0.69 P¼0.76 P¼0.15 P¼0.62 P¼0.60 P¼64
ER and PR negative 615 20.21 (15.78) 20.3 1.00 (Referent) 1.00 (Referent) 485 16.93 (15.10) 14.8 1.00 (Referent) 1.00 (Referent)
ER or PR positive 2672 20.09 (15.88) 20.1 0.96 0.77–1.19 0.97 0.77–1.21 2401 16.04 (15.37) 14.0 0.93 0.71–1.22 0.94 0.70–1.24
Type of surgery P¼0.55 P¼0.47 P¼0.49 P¼0.87 P¼0.31 P¼0.04 P¼0.04 P¼0.12
Mastectomy 1795 20.36 (16.14) 20.6 1.00 (Referent) 1.00 (Referent) 1555 16.62 (15.79) 15.4 1.00 (Referent) 1.00 (Referent)
Lumpectomy 1515 19.82 (15.48) 19.5 0.94 0.79–1.12 0.99 0.83–1.18 1351 15.75 (14.78) 12.8 0.81 0.65–0.99 0.84 0.68–1.04
Chemotherapy P¼0.52 P¼0.15 P¼0.24 P¼0.33 Po0.001 P¼0.93 P¼0.62 P¼0.58
No chemotherapy 1871 20.18 (16.35) 21.0 1.00 (Referent) 1.00 (Referent) 1686 15.47 (15.83) 14.2 1.00 (Referent) 1.00 (Referent)
In treatment/treated 1435 20.05 (15.17) 19.0 1.13 0.92–1.39 1.11 0.90–1.38 1217 17.28 (14.56) 14.3 1.07 0.83–1.37 1.08 0.83–1.40
Radiotherapy I P¼0.004 P¼0.02 P¼0.004 P¼0.005 P¼0.09 P¼0.43 P¼0.42 P¼0.31
No radiotherapy 680 18.51 (15.70) 16.5 1.00 (Referent) 1.00 (Referent) 619 15.50 (15.44) 13.2 1.00 (Referent) 1.00 (Referent)
To be treated after chemotherapy 1171 20.47 (15.09) 20.2 1.56 1.20–2.02 1.56 1.19–2.04
Treated with radiotherapy 1456 20.59 (16.46) 21.8 1.29 1.02–1.65 1.31 1.02–1.67 2284 16.43 (15.30) 14.5 1.11 0.86–1.45 1.15 0.88–1.50
Hormone therapy I P¼0.22 P¼0.02 P¼0.54 P¼0.69 P¼0.06 P¼0.17 P¼0.16 P¼0.26
No hormone therapy 1223 19.55 (15.77) 19.3 1.00 (Referent) 1.00 (Referent) 1029 15.62 (15.20) 13.0 1.00 (Referent) 1.00 (Referent)
To be treated after chemotherapy 821 19.95 (14.71) 17.9 1.15 0.88–1.49 1.12 0.86–1.47
In treatment 1243 20.83 (16.67) 22.5 1.07 0.87–1.31 1.04 0.84–1.28 1861 16.58 (15.42) 14.9 1.17 0.94–1.46 1.14 0.91–1.43
Abbreviations: CI¼confidence interval; ER¼estrogen receptor; IES¼impact of events scale; OR¼odds ratio; PR¼progesterone positive; PTSS¼post-traumatic stress
symptom.
aPTSS¼IES; severe PTSS¼IES total score X35.
bSevere PTSS at 3 months post surgery fully adjusted for socio-demographic and health status variables related
(Po0.25) to severe PTSS in the univariate and/or age-adjusted analyses (age, marital status, children, education, social status, personal income and household net wealth per
person, psychiatric history, and comorbidity).
cSevere PTSS at 15 months post surgery fully adjusted for socio-demographic and health status variables related (Po0.25) to severe
PTSS in the univariate and/or age-adjusted analyses (age, children, education, social status, personal income and household net wealth, psychiatric history, and comorbidity).
Age- and fully adjusted OR’s in bold differs significantly (95% CI) from the reference group (OR¼1.00). Missing observations are not shown. As a consequence totals
(N) differs slightly.
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s44 to 283), there was considerable between- and within-study
variability in the timing of assessment. However, when comparing
our results with the scores found in the studies with assessment
times most similar to ours (between 0 and 12 months), the intrusion
and avoidance scores in our sample (10.1 and 10.0 at 3 months and
7.8 and 8.4 at 15 months) were similar or lower than the range of the
scores found in these studies (intrusion: 9.1–14.0 and avoidance
12.2–15.0; a list of references can be obtained on request to the first
author). At 3 months post surgery, we found a prevalence of severe
PTSS of 20.1%. At 1 year later, the prevalence was reduced to 14.3%.
One out of four women experienced severe PTSS during the first
15 months following surgery. In comparison, the lifetime prevalence
of sufficiently severe PTSS to warrant a diagnosis of PTSD in general
population studies has been found to be around 7% (Kessler et al,
2005). Our results thus confirm that a significant proportion of
women experience severe breast cancer-related PTSS, and that a
reduction in the prevalence of severe PTSS can be expected during
the first year after surgery. However, approximately half of the
women with severe PTSS at 3 months post surgery also had severe
PTSS at 15 months, indicating that these women are at increased
risk of persistent severe PTSS.
Our results, based on data from national registries with
un-biased pre-cancer information, suggest that women with lower
SES and previous physical or mental illness have a substantially
higher risk of developing severe cancer-related PTSS than women
with high social status and no previous illnesses. When adjusting
for severe PTSS and PTSS at 3 months, women with high SES also
improved more during the first year after surgery than women
with lower SES, suggesting that PTSS may be more transient for
women in high SES groups.
In the general population, the prevalence of sufficiently severe
PTSS to warrant a diagnosis of PTSD is usually lower among
older individuals compared with younger (Kessler et al, 2005).
Likewise, younger cancer patients are generally more distressed
after receiving their cancer diagnosis than older patients
(Kangas et al, 2002). In contrast, the youngest women in our
study had the lowest prevalence of severe PTSS at 3 months,
whereas no differences were found for PTSS mean scores. At
15 months, no significant difference in severe PTSS was found
between the youngest and the oldest patients, but younger patients
now demonstrated significantly elevated PTSS mean scores.
Although we have no clear explanation, the difference between
our and previous results could stem from differences in timing and
age characteristics of the studied samples.
Of the clinical factors, nodal status was a risk factor for severe
PTSS at both 3 and 15 months post surgery. The prevalence of
severe PTSS for women with 43 affected lymph nodes was
markedly higher at 15 months (20.5%) than for women with no
lymph node involvement (12.3%). Additional multivariate analyses
confirmed that nodal involvement was the only independent
clinical risk factor, suggesting that it is perceived disease severity
rather than treatment that has a significant role in the development
of severe cancer-related PTSS in early breast cancer. It may,
therefore, be important to discuss the prognostic implications
Table 4 Self-reported health related risk factors for cancer-related PTSS and severe PTSS
a
3 Months post surgery 15 Months post surgery
PTSS
Severe
PTSS
Severe PTSS
age adjusted
Severe PTSS
fully adjusted
b
PTSS
Severe
PTSS
Severe PTSS
age adjusted
Severe PTSS
fully adjusted
c
N Mean (s.d.) (%) OR (95% CI) OR (95% CI) N Mean (s.d.) (%) OR (95% CI) OR (95 % CI)
Smoking status P¼0.002 Po0.001 Po0.001 P¼0.07 P¼0.19 P¼0.001 P¼0.001 P¼0.19
Never Smoker 1308 18.98 (15.48) 18.1 1.00 (Referent) 1.00 (Referent) 1155 15.44 (14.82) 12.9 1.00 (Referent) 1.00 (Referent)
Ex-smoker 989 19.71 (14.84) 17.9 1.00 0.81–1.24 1.05 0.84–1.31 879 15.83 (14.16) 12.5 0.97 0.74–1.26 1.03 0.79–1.36
1–9 per day 174 20.47 (16.27) 21.3 1.19 0.80–1.76 1.11 0.74–1.65 157 16.82 (15.14) 12.7 0.98 0.60–1.62 0.86 0.51–1.45
10–19 per day 458 20.39 (16.98) 26.4 1.64 1.27–2.11 1.44 1.11–1.88 388 17.37 (17.30) 17.3 1.41 1.03–1.93 1.19 0.85–1.66
X20 per day 333 22.30 (17.87) 24.6 1.56 1.17–2.08 1.30 0.95–1.77 283 18.72 (17.52) 21.2 1.83 1.31–2.56 1.50 1.04–2.15
Alcohol P¼0.02 Po0.001 Po0.001 P¼0.01 P¼0.04 P¼0.001 P¼0.001 P¼0.09
Never drinker 331 20.42 (16.49) 21.8 1.00 (Referent) 1.00 (Referent) 282 16.96 (17.01) 21.3 1.00 (Referent) 1.00 (Referent)
Ex-drinker 176 24.23 (17.34) 30.7 1.71 1.13–2.59 1.69 1.09–2.62 148 18.96 (17.10) 20.3 0.94 0.58–1.55 0.89 0.53–1.51
o1 drink per day 1344 19.79 (15.70) 18.7 0.89 0.66–1.20 1.06 0.77–1.45 1187 16.15 (14.50) 12.5 0.53 0.38–0.74 0.62 0.44–0.89
X1 and o2 drinks per day 803 19.09 (14.91) 17.1 0.75 0.55–1.04 1.03 0.73–1.44 713 15.25 (15.06) 13.6 0.58 0.41–0.83 0.77 0.52–1.12
X2 and o3 drinks per day 385 20.01 (15.80) 21.3 0.96 0.67–1.38 1.33 0.91–1.94 333 15.42 (15.52) 12.3 0.52 0.34–0.80 0.67 0.42–1.06
X3 drinks per day 229 21.62 (16.97) 25.3 1.20 0.81–1.79 1.68 1.10–2.56 207 18.44 (16.69) 16.9 0.75 0.47–1.19 0.93 0.57–1.53
Body mass index P¼0.10 P¼0.04 P¼0.13 P¼0.49 P¼0.41 P¼0.09 P¼0.09 P¼0.37
Normal weight (418.5 and o25) 1898 19.59 (15.36) 18.3 1.00 (Referent) 1.00 (Referent) 1686 15.72 (14.89) 12.8 1.00 (Referent) 1.00 (Referent)
Underweight (p18.5) 84 18.04 (15.94) 19.0 1.02 0.58–1.78 0.87 0.49–1.55 71 15.23 (15.36) 11.3 0.87 0.41–1.84 0.74 0.34–1.61
Overweight (X25 and o30) 902 21.07 (16.23) 22.4 1.24 1.02–1.51 1.16 0.94–1.42 787 16.98 (15.76) 15.9 1.29 1.02–1.64 1.21 0.94–1.55
Obese or severely obese (X30) 375 20.72 (16.42) 22.1 1.23 0.94–1.61 1.01 0.76–1.35 321 16.82 (15.80) 16.5 1.35 0.98–1.88 1.06 0.75–1.51
Physical function (SF-36 PF) Po0.001 Po0.001 Po0.001 Po0.001 Po0.001 Po0.001 Po0.001 Po0.001
100 537 14.25 (13.70) 9.7 1.00 (Referent) 1.00 (Referent) 476 11.34 (12.95) 6.7 1.00 (Referent) 1.00 (Referent)
490 and o100 817 17.53 (13.91) 14.2 1.57 1.11–2.22 1.63 1.14–2.33 725 14.05 (13.25) 9.4 1.43 0.92–2.21 1.56 0.99–2.48
480 and p90 838 19.90 (15.04) 18.6 2.16 1.54–3.02 2.18 1.54–3.08 747 15.77 (14.97) 13.0 2.07 1.36–3.14 2.17 1.40–3.37
470 and p80 537 23.23 (16.11) 25.0 3.12 2.21–4.41 3.12 2.18–4.47 474 18.88 (15.72) 17.9 3.03 1.98–4.66 3.24 2.06–5.08
X0 and p70 564 26.76 (18.08) 35.8 5.00 3.58–6.99 4.31 3.01–6.16 475 22.30 (17.91) 26.9 5.19 3.43–7.84 4.94 3.14–7.75
Abbreviations: CI¼confidence interval; IES¼impact of events scale; OR¼odds ratio; PTSS¼post-traumatic stress symptom.
aPTSS¼IES; severe PTSS¼IES total score X35.
bSevere PTSS at 3 months post surgery fully adjusted for socio-demographic, health status, and clinical baseline variables related to severe PTSS (Po0.25) in the univariate and/or
age-adjusted analyses (age, marital status, children, education, social status, personal income and household net-wealth per person, psychiatric history, comorbidity, nodal status,
chemotherapy, radiotherapy, and hormone therapy).
cSevere PTSS at 15 months post surgery fully adjusted for socio-demographic, health status, and clinical baseline variables
related to severe PTSS (Po0.25) in the univariate and/or age-adjusted analyses (age, children, education, social status, personal income and household net-wealth, psychiatric
history, comorbidity), nodal status, surgery, and hormone therapy). Age- and fully adjusted OR’s in bold differs significantly (95% CI) from the reference group (OR¼1.00).
Missing observations are not shown. As a consequence totals (N) differs slightly. Smoking status, use of alcohol, weight, height, and physical function was measured by
questionnaire at baseline.
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swith the affected women to avoid potential misconceptions.
It should also be taken into consideration that SES risk factors
for severe PTSS such as lower education may also pose a
communicative barrier.
Although some studies have indicated that alcohol consumption
and smoking habits may be associated with PTSD (Rasmusson
et al, 2006; Mcfarlane et al, 2009), these health behaviours were
nonsignificant in the fully adjusted analyses. PF was clearly the
strongest predictor of severe PTSS. Although evaluated after the
cancer diagnosis, the age-stratified scores of PF in our study
closely resemble national norms (Bjørner et al, 1997; Christensen
et al, 2009). This suggests that the levels of PF found generally
correspond to pre-cancer levels, and that the low PF therefore can
be regarded as an independent risk factor of cancer-related severe
PTSS, rather than a consequence hereof.
Although we have no clear explanation as to the association
found between poor PF and greater cancer-related PTSS, possible
biological, psychological, and social mechanisms could be
considered in future studies. First, poor PF could be hypothesised
to be at least partly related to various forms of disease activity,
for example, inflammation. As proinflammatory cytokines have
been shown to induce sickness behaviour and have been linked to
psychological responses, for example, depression (Dantzer et al,
2008), it is possible that the link is mediated by proinflammatory
cytokines. Perhaps more importantly, long-term cancer survivors
have been shown to attribute problems, such as lack of energy and
poor body image to their cancer (Phipps et al, 2008). A second,
psychological explanation could therefore be that the women with
poor PF, regardless of its aetiology, may have attributed their poor
PF to their breast cancer, thus experiencing their disease as more
serious, with subsequent greater cancer-related distress as
result. Finally, poor PF may induce limitations in social function
(Fialka-Moser et al, 2003), which in turn may be associated with
poorer social support and subsequent increases in distress.
In line with previous findings (Van Hoof et al, 2009), our results
show that the event itself may have a less clear role in relation to
the development of severe PTSS than suggested in DSM-IV
(American Psychiatric Association, 2000). It has been suggested
that the nature of the event is more likely to be central as a
predictor of post-traumatic stress in high-intensity stressors
(e.g., direct experience of combat, torture, violent sexual assaults),
whereas pre-existing individual risk factors may be the most
important predictors of post-traumatic stress following relatively
less extreme events (e.g., serious illness or bereavement; Van Hoof
et al, 2009). By the above definition, primary breast cancer can be
considered a less extreme traumatic stressor. Although one factor
related to the intensity of the traumatic event, disease severity, was
a risk factor for severe PTSS, our findings generally underline the
importance of focusing on pre-existing individual risk factors,
such as SES, previous mental or physical illness, and PF when
screening for PTSS in breast cancer.
Although this study has several strengths, a few limitations
should be mentioned. The IES score is based on symptoms
experienced within the last 7 days. Other studies using other
measures may have used longer time frames, and we may thus
have underestimated the prevalence of PTSS in our sample.
Furthermore, the participants in this study were generally younger,
healthier, and had higher SES than non-participants resulting in a
potential bias of underestimating the number of women suffering
from severe PTSS. On the other hand, the IES only includes the
DSM-IV criteria B and C (American Psychiatric Association, 2000),
which may have lead us to overestimate the prevalence of
sufficiently severe PTSS to suggest possible PTSD. Nevertheless,
the IES cutoff of X35 used in our study has previously shown good
diagnostic performance (Neal et al, 1994; Wohlfarth et al, 2003).
CONCLUSION
Although our measure of PTSS because of the large sample
size was questionnaire-based rather than based on clinical
interviews and a diagnosis of PTSD, therefore, could not be
confirmed, our results show that breast cancer is a significant
traumatic experience for a considerable proportion of disease-free
women, even more than one year after surgery. Although nodal
status was the most important clinical risk factor for severe breast
cancer-related PTSS, pre-morbid conditions, such as SES, previous
mental illness, and PF also were substantial risk factors.
As most of these potential risk factors can be identified at the
time of the diagnosis, this presents an opportunity to provide early
preventive interventions for women at high risk of severe cancer-
related PTSS.
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